These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 321857)

  • 21. Initial events in the formation of immune deposits in passive Heymann nephritis. gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane.
    Kerjaschki D; Miettinen A; Farquhar MG
    J Exp Med; 1987 Jul; 166(1):109-28. PubMed ID: 2885390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new glomerular antigen in passive Heymann's nephritis.
    Jeraj K; Vernier RL; Sisson SP; Michael AF
    Br J Exp Pathol; 1984 Aug; 65(4):485-98. PubMed ID: 6380558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of passive Heymann nephritis in complement component 6-deficient PVG rats.
    Spicer ST; Tran GT; Killingsworth MC; Carter N; Power DA; Paizis K; Boyd R; Hodgkinson SJ; Hall BM
    J Immunol; 2007 Jul; 179(1):172-8. PubMed ID: 17579035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria.
    Hara M; Batsford SR; Mihatsch MJ; Bitter-Suermann D; Vogt A
    Lab Invest; 1991 Aug; 65(2):168-79. PubMed ID: 1881120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glomerular and vascular IgG deposits in HgCl2 nephritis: role of circulating antibodies and of immune complexes.
    Houssin D; Druet E; Hinglais N; Verroust P; Grossetete J; Bariety J; Druet P
    Clin Immunol Immunopathol; 1983 Nov; 29(2):167-80. PubMed ID: 6226464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis).
    Kerjaschki D; Neale TJ
    J Am Soc Nephrol; 1996 Dec; 7(12):2518-26. PubMed ID: 8989729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of antigen distribution on the mediation of immunological glomerular injury.
    Salant DJ; Adler S; Darby C; Capparell NJ; Groggel GC; Feintzeig ID; Rennke HG; Dittmer JE
    Kidney Int; 1985 Jun; 27(6):938-50. PubMed ID: 3894765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study on the immune complex formation mechanisms of passive Heymann nephritis--role of two different renal tubular epithelial antigens].
    Yamagata K; Koyama A; Kobayashi M; Narita M
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1045-52. PubMed ID: 2287096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible involvement of terminal complement complex in active Heymann nephritis.
    de Heer E; Daha MR; Bhakdi S; Bazin H; van Es LA
    Kidney Int; 1985 Feb; 27(2):388-93. PubMed ID: 3886996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of passive Heymann glomerulonephritis: chlorpromazine inhibits antibody-mediated redistribution of cell surface antigens and prevents development of the disease.
    Camussi G; Noble B; Van Liew J; Brentjens JR; Andres G
    J Immunol; 1986 Mar; 136(6):2127-35. PubMed ID: 3485141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. IV. Investigations into the pathogenesis of the model.
    Fleuren GJ; vd Lee R; Greben HA; Van Damme BJ; Hoedemaeker PJ
    Lab Invest; 1978 Apr; 38(4):496-501. PubMed ID: 147960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement-independent nephrotoxic serum nephritis in Munich Wistar rats. Immunologic and ultrastructural studies.
    Pilia PA; Boackle RJ; Swain RP; Ainsworth SK
    Lab Invest; 1983 May; 48(5):585-97. PubMed ID: 6341711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental gold nephropathy in guinea pigs: detection of autoantibodies to renal tubular antigens.
    Ueda S; Wakashin M; Wakashin Y; Yoshida H; Iesato K; Mori T; Mori Y; Akikusa B; Okuda K
    Kidney Int; 1986 Feb; 29(2):539-48. PubMed ID: 3084839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies in molecular pathology. I. Localization and pathogenic role of heterologous immune complexes.
    MELLORS RC; BRZOSKO WJ
    J Exp Med; 1962 May; 115(5):891-902. PubMed ID: 14472423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary excretion of C5b-9 reflects disease activity in passive Heymann nephritis.
    Pruchno CJ; Burns MW; Schulze M; Johnson RJ; Baker PJ; Couser WG
    Kidney Int; 1989 Jul; 36(1):65-71. PubMed ID: 2681928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe glomerular epithelial cell damage does not prevent passive Heyman nephritis in rats.
    Bertani T; Remuzzi G; Poggi A; Delaini F; Sacchi G; Morassi L; Verroust P; Mecca G; Donati MB
    Clin Exp Immunol; 1983 Jan; 51(1):38-44. PubMed ID: 6339125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accelerated passive Heymann nephritis in rats as an experimental model for membranous glomerulonephritis and effects of azathioprine and prednisolone on the nephritis.
    Ito M; Aono Y; Suzuki A; Nagamatsu T; Suzuki Y
    Jpn J Pharmacol; 1989 Jan; 49(1):101-10. PubMed ID: 2724671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Passive Heymann nephritis in pre- and post-natal rats.
    Challice J; Barabas AZ; Cornish J; Bruce JW; Lannigan R
    Br J Exp Pathol; 1986 Dec; 67(6):915-24. PubMed ID: 3542009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen.
    Neale TJ; Ojha PP; Exner M; Poczewski H; Rüger B; Witztum JL; Davis P; Kerjaschki D
    J Clin Invest; 1994 Oct; 94(4):1577-84. PubMed ID: 7929834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.